HLOSF
Price:
$1.8
Market Cap:
$29.71B
Healios K.K. is a biotechnology firm specializing in the innovation, development, production, and commercialization of cell therapy and regenerative medicine products, with operations spanning Japan, Europe, and the United States. The company's robust pipeline features several advanced cellular and tissue-based therapies: iPSC-derived regenerative medicines HLCR011 and HLCR012, which target age-related macular degeneration; HLCL041, an iPSC regenerative medicine for metabolic liver disease; HLCM051, a regenerative treatment for ischemic stroke and acute respiratory distress syndrome; and HLCN061, currently under development for solid tumor indications. Furthermore, Healios K.K. maintains a c...[Read more]
Industry
Biotechnology
IPO Date
2020-11-09
Stock Exchange
OTC
Ticker
HLOSF
According to Healios K.K.’s latest financial reports and current stock price. The company's current PE Ratio is -10.59. This represents a change of -299.03% compared to the average of 5.32 of the last 4 quarters.
The mean historical PE Ratio of Healios K.K. over the last ten years is -16.26. The current -10.59 PE Ratio has changed 6.41% with respect to the historical average. Over the past ten years (40 quarters), HLOSF's PE Ratio was at its highest in in the June 2017 quarter at 86.16. The PE Ratio was at its lowest in in the December 2016 quarter at -67.10.
Average
-16.26
Median
-14.93
Minimum
-48.80
Maximum
-2.93
Discovering the peaks and valleys of Healios K.K. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 259.82%
Maximum Annual PE Ratio = -2.93
Minimum Annual Increase = -78.49%
Minimum Annual PE Ratio = -48.80
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -13.30 | 259.82% |
| 2024 | -3.70 | 25.99% |
| 2023 | -2.93 | -0.69% |
| 2022 | -2.96 | -78.49% |
| 2021 | -13.74 | -25.13% |
| 2020 | -18.35 | 8.06% |
| 2019 | -16.98 | 5.24% |
| 2018 | -16.13 | -66.94% |
| 2017 | -48.80 | 89.83% |
| 2016 | -25.71 | -41.39% |
The current PE Ratio of Healios K.K. (HLOSF) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
-6.65
5-year avg
-7.33
10-year avg
-16.26
Healios K.K.’s PE Ratio is less than Avacta Group Plc (-8.31), less than BioInvent International AB (publ) (-4.50), less than Northwest Biotherapeutics, Inc. (-6.86), less than PureTech Health plc (-3.82), greater than MedinCell S.A. (-46.47), less than CytoDyn Inc. (-9.20), less than Immutep Limited (-0.84), less than Clinuvel Pharmaceuticals Limited (15.03), less than Cresco Labs Inc. (-2.19), less than Cellectis S.A. (-4.67),
| Company | PE Ratio | Market cap |
|---|---|---|
| -8.31 | $454.97M | |
| -4.50 | $216.40M | |
| -6.86 | $312.23M | |
| -3.82 | $413.81M | |
| -46.47 | $1.23B | |
| -9.20 | $383.53M | |
| -0.84 | $73.69M | |
| 15.03 | $348.84M | |
| -2.19 | $290.46M | |
| -4.67 | $251.93M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Healios K.K. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Healios K.K. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Healios K.K.'s PE Ratio?
How is the PE Ratio calculated for Healios K.K. (HLOSF)?
What is the highest PE Ratio for Healios K.K. (HLOSF)?
What is the 3-year average PE Ratio for Healios K.K. (HLOSF)?
What is the 5-year average PE Ratio for Healios K.K. (HLOSF)?
How does the current PE Ratio for Healios K.K. (HLOSF) compare to its historical average?